The Emirates Drug Establishment (EDE), in coordination with Nestlé, has announced a voluntary and precautionary recall of a limited number of infant formula products, including NAN Comfort 1, NAN Optipro 1, NAN Supreme PRO 1, 2, 3, S-26 Ultima 1, 2, 3, and Alfamino.
The recall was initiated after one of the raw materials used in production was found to contain traces of the Bacillus cereus bacteria, prompting action to protect consumer health and safety. The Emirates Drug Establishment clarified that, to date, no illness or adverse events linked to the affected batches have been reported or confirmed, and that all other Nestlé products remain safe for consumption.
The Establishment emphasised that product safety and quality, particularly when it comes to children’s health, is the Establishment’s highest priority.
The EDE noted that, in coordination with Nestlé, the affected batches have been quarantined in the company’s and distributors’ warehouses, and that efforts are ongoing to complete the recall of any remaining quantities in accordance with approved regulatory procedures.
It further said that these measures were undertaken to protect public health and safety and that the recall process is being conducted in coordination with the relevant regulatory authorities in the UAE to ensure the complete removal of the affected batches from all points of sale, including online retail platforms.